Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation

Nasal potential difference (NPD) is used as a biomarker of the cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC) activity. We evaluated methods to detect changes in chloride and sodium transport by NPD based on a secondary analysis of a Phase II CFTR-mod...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Rowe, Steven M., Liu, Bo, Hill, Aubrey, Hathorne, Heather, Cohen, Morty, Beamer, John R., Accurso, Frank J., Dong, Qunming, Ordoñez, Claudia L., Stone, Anne J., Olson, Eric R., Clancy, John P.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3724869/
https://ncbi.nlm.nih.gov/pubmed/23922647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0066955
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items